Search clinical trials for: Glucagon Secretion

Total 1238 results

Mayo Clinic

Not yet recruiting

Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes

PreDiabetes

United States
Mayo Clinic

Not yet recruiting

Insulin and Insulin Pulses During Fasting

PreDiabetes

United States
University of Sao Paulo General Hospital

Recruiting

L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP

Type 2 Diabetes Mellitus in Obese | Severe Obesity

Brazil
University of Pennsylvania
Children's Hospital of Philadelphia

Recruiting

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Diabetes | Cystic Fibrosis | Pancreatic Insufficiency | Abnormal Glucose Tolerance

United States
The University of Texas Health Science Center at...

Recruiting

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

Hypoglycemia | Post Bariatricsurgery

United States
Novo Nordisk A/S

Completed

Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
David D'Alessio, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Incretin Action in Physiology and Diabetes

Insulin Secretion

United States
Adrian Vella
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin Secretion

Healthy

United States
University of Maryland, Baltimore

Terminated

Pharmacogenomics of GLP1 Receptor Agonists

Type 2 Diabetes

United States
University Health Network, Toronto
Kensington Screening Clinic

Completed

Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids (GLP-2 Biopsy)

Hyperlipidemias

Canada
St. James's Hospital, Ireland
University College Dublin; University of Dublin, Trinity College

Completed

Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer

Stomach Neoplasms | Malnutrition | Esophageal Neoplasms | Weight Loss

Ireland
Acibadem University

Completed

Effects of Low/No Calorie Sweeteners on Glucose Tolerance

Glucose Tolerance | Healthy Population

Turkey
David D'Alessio, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Glucagon Regulation of Glucose Metabolism

Insulin Secretion

United States
David D'Alessio, M.D.
Merck Sharp & Dohme LLC

Completed

DPP4 Inhibition & Beta Cell Function

Healthy

United States
University of Aarhus
Region MidtJylland Denmark

Completed

Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia

Obesity | Hypoglycemia | Surgery

Denmark
University Hospital, Gentofte, Copenhagen

Completed

Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion (Px-Meal)

Diabetes After Total Pancreatectomy

Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

The Anatomical Location, Cellular Origin and Molecular Basis of Gut-derived Glucagon Secretion

Glucose Metabolism Disorders

Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

The Effect of Insulin-induced Hypoglycaemia on Gut-derived Glucagon Secretion (Px-Hypo)

Diabetes After Total Pancreatectomy

Denmark
University Hospital, Gentofte, Copenhagen

Completed

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea (HNF1A-Clamp)

Maturity-Onset Diabetes of the Young, Type 3

Denmark
University of Copenhagen
Rigshospitalet, Denmark

Unknown

Studies of the Early Meal Phase in Healthy Individuals - Nutrient Absorption and Gastrointestinal Hormone Secretion

Healthy

Denmark
Washington University School of Medicine
American Diabetes Association

Completed

The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion

Pre-diabetes

United States
University of Aarhus

Completed

The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion

Diabetes Mellitus Type 2

Denmark
Washington University School of Medicine
American Diabetes Association

Withdrawn

Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy

Does the Vagus Nerve Mediate the Effects of Xenin-25

United States
Hvidovre University Hospital

Unknown

Glucose Absorption and Gut Hormone Secretion After Gastric Bypass

Overweight

Denmark
Minneapolis Veterans Affairs Medical Center

Suspended

Protein, Amino Acids & Insulin & Glucagon Secretion in Humans

Metabolic Syndrome | Type 2 Diabetes

United States
Guangwei Li

Completed

Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics

Insulin Resistance | Insulin Secretion

China
University of Chicago

Completed

Incretin Regulation of Insulin Secretion in Monogenic Diabetes

Monogenic Diabetes

United States
Kirstine Nyvold Bojsen-Moeller
University of Copenhagen

Unknown

The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation

Overweight | Bariatric Surgery (Gastric Bypass)

Denmark
Novartis

Completed

Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects

Healthy | Type-2 Diabetes

Germany
Diabeteszentrum Bad Lauterberg im Harz

Completed

GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes

Type 2 Diabetes

Germany
Rigshospitalet, Denmark

Completed

Exercise, Glucose Kinetics, and the Incretin Effect

Type 2 Diabetes

Denmark
Michael A. Nauck

Completed

Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

Type 2 Diabetes

Germany
Diabeteszentrum Bad Lauterberg im Harz

Completed

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Type 2 Diabetes
Hvidovre University Hospital

Unknown

The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate (ALFA-1)

Type 1 Diabetes
University Hospital, Basel, Switzerland

Completed

Role of the Gut Sweet Taste Receptor in the Secretion of Glucagon-like Peptide-1 and Peptide YY

Taste Disorder, Primary, Sweet

Switzerland
Filip Krag Knop
University of Copenhagen

Completed

The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion

Denmark
Eli Lilly and Company

Completed

Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose

Diabetes Mellitus, Type 2

Germany
Lund University

Completed

Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers

Healthy Volunteers Recruited From the General Population

Sweden
University Hospital, Gentofte, Copenhagen

Completed

The Effect of GLP-1 on the Inhibition of Glucagon Secretion

Type 1 Diabetes | Type 2 Diabetes

Denmark
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Unknown

Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects

Vagotomy, Truncal

Denmark
University Hospital, Basel, Switzerland

Completed

Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls

Non Alcoholic Fatty Liver Disease | Non Alcoholic Steatohepatitis

Switzerland
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Unknown

Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion

Liver Transplantation

Denmark
University Hospital, Basel, Switzerland

Completed

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

Appetite and General Nutritional Disorders | Hormone Replacement

Switzerland
Hvidovre University Hospital

Completed

Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus

Type-1 Diabetes Mellitus

Denmark
Charite University, Berlin, Germany

Unknown

Glucagon Modulation of Ghrelin Secretion

Obesity | Diabetes Mellitus, Type 1 | Healthy Subjects

Germany
University Hospital, Gentofte, Copenhagen
University of Copenhagen; Hvidovre University Hospital; Glostrup University Hospital...

Unknown

Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)

Hyperglycemia | Glucose Intolerance | Hyperglucagonemia
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes

Diabetes Mellitus

Denmark
The University of Texas Health Science Center at...
Novartis

Completed

Acute Metabolic Effects of LAF 237 in Type 2 Diabetics

Type 2 Diabetes Mellitus

United States
Brigham and Women's Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

LIROH - Liraglutide for Obesity in HIV (LIROH)

HIV Infections | Obesity

South Africa

Search clinical trials for: Glucagon Secretion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations